Should serum IGF-I concentrations be monitored routinely during growth hormone therapy?

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 2, 2004, Pages 141-142

  Papagianni, Maria ^a   Stanhope, Richard ^a,b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ACCURACY; ACROMEGALY; ANALYTIC METHOD; BREAST CANCER; CARDIOVASCULAR DISEASE; COLON TUMOR; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE PREDISPOSITION; DOSE RESPONSE; GROWTH HORMONE DEFICIENCY; HEALTH CARE COST; HORMONAL THERAPY; HUMAN; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; NOTE; PATIENT MONITORING; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; RISK FACTOR;

EID: 2542520207     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.2.141     Document Type: Note

References (15)

1. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998; 83: 3913-3919
2. Attanasio A, Attie K, Baxter R, et al. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998; 83: 379-381.
3. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: Diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001; 11: 137-165.
4. Forme SM, McNally RJQ, Cartwright RA, Belchetz PE, for the United Kingdom Acromegaly Study Group. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998; 83: 2730-2734.
5. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M. Acromegaly, colonic polyps and carcinoma. Clin Endocrinol 1997; 47: 17-22.
6. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 1999; 91: 620-625.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998; 279: 563-566.
8. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998; 351: 1393-1396.
9. Rosen T, Bengtsson B-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
10. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360: 273-277.
11. Cohen P, Bright GM, Rogol AD, Kappelgaard A-M, Rosenfeld RG. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 2002; 87: 90-98.
12. Ranke MB, Schweizer R, Elmlinger MW, Weber K, Binder G, Schwarze CP, Wollmann HA. Relevance of IGF-1 IGF BP-3, and IGF BP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents. Horm Res 2001; 55: 115-124.
13. Caret J-C, Mathivon L, Gendrlel C, Ducret J-P, Chaussain J-L. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998; 83: 1462-1466.
14. Sas T, De Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 1999; 84: 3064-3070.
15. Allen DB, Rundle AC, Graves DA, Blethen SL. Risk of leukemia in children treated with human growth hormone: review and reanalysis. J Pediatr 1997; 131: S32-36.